What is the global market size of Flow Cytometry Market?

Flow Cytometry Market size was valued at USD 3971.4 million in 2019 and is poised to grow from USD 4255.8 million in 2023 to USD 6995.5 million by 2031, growing at a CAGR of 7.17% in the forecast period (2024-2031).

Who are the key vendors in the Global Flow Cytometry Market?

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players are holding a huge share of the market and are likely to remain in a similar competitive environment for the next few years. Key Flow Cytometry market players in the market are Becton, Dickinson and Company, Danaher Corporation Sysmex Corporation, Bio-Rad Laboratories Inc, Luminex Corporation, etc. 'Thermo Fisher Scientific, Inc. (US)', 'Luminex Corporation (US)', 'BD Biosciences', 'Beckman Coulter, Inc.', 'Sony Biotechnology Inc.', 'Sysmex Partec GmbH', 'Merck KGaA', 'Miltenyi Biotec', 'Bio-Rad Laboratories, Inc.', 'Agilent Technologies', 'Apogee Flow Systems Ltd.', 'Cytek Biosciences, Inc.', 'Enzo Life Sciences, Inc.', 'Fluxion Biosciences, Inc.', 'GE Healthcare Life Sciences', 'Nexcelom Bioscience LLC', 'ACEA Biosciences, Inc.', 'Intellicyt Corporation', 'Partek Incorporated', 'Propel Labs.'.

What is the key driver of Global Flow Cytometry Market?

Flow cytometry aids in the analysis of cell surface and intracellular molecule expression. It is used to characterize and define various types of cells in a heterogeneous cell population, as well as to assess the purity of isolated subpopulations. The Flow Cytometry market is being driven by rising R&D initiatives by various key players for the development of multicolor assays and advanced reagents for analysis.

What is the key market trend for Global Flow Cytometry Market?

Flow cytometry is considered as an excellent tool for characterizing, identifying, and isolating stem cells for research and potential clinical applications. Recent advances in flow cytometric hardware, reagents, and software have enabled stem cell biologists to more fully identify and isolate rare cells. With such widespread use of flow cytometry for disease diagnosis and early detection, adoption in stem cell research is propelling the growth of the Flow cytometry Market.

Flow Cytometry Companies

Q: Which region accounted for the largest share in Global Flow Cytometry Market?

In 2021, North America dominated the flow cytometry market. Throughout the study period, the region is expected to dominate the market. This dominance can be attributed to the United States' high healthcare spending, well-established healthcare infrastructure, and widespread adoption of technologically advanced flow cytometry solutions. Furthermore, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies, have created a significant demand for flow cytometry solutions for research purposes. During the forecast period, the Flow Cytometry market in the Asia Pacific is expected to grow at an exponential rate. This region's profitable growth is also a result of ongoing government support for the establishment of the pharmaceutical industry in developing markets.

Flow Cytometry Market Competitive Landscape

Top Players Company Profiles

Becton, Dickinson, and Company (US)
Danaher Corporation (US)
Thermo Fisher Scientific, Inc. (US)
Agilent Technologies, Inc. (US)
Sony Group Corporation (Japan)
Bio-Rad Laboratories, Inc. (US)
Miltenyi Biotec GmbH (Germany)
Enzo Biochem, Inc. (US)
Sysmex Corporation (Japan)
bioMérieux S.A. (France)
Cytonome/ ST, LLC (US)
Sartorius AG (Germany)
Cytek Biosciences, Inc. (US)
Union Biometrica, Inc. (US)
Fluxion Biosciences, Inc. (US)
Apogee Flow Systems Ltd. (UK)
Merck KGaA (Germany)
Beckman Coulter, Inc. (US)
Stratedigm, Inc. (US)
Nanocellect Biomedical (US)

FAQs

Global Flow Cytometry Market was valued at USD 3.97 Billion in 2022 and is poised to grow from USD 4.25 Billion in 2023 to USD 6.99 Billion by 2031, at a CAGR of 7.17% over the forecast period (2024-2031).

The flow cytometry market is considered highly consolidated due to the presence of very few players in the market. These players hold a huge share of the market and are likely to remain in a similar competitive environment for the next few years. BD Biosciences is a leader in the flow cytometry market, known for its wide range of flow cytometry devices, reagents and software solutions. The company emphasizes innovation and product development to meet research and clinical needs. 'Becton, Dickinson, and Company (US)', 'Danaher Corporation (US)', 'Thermo Fisher Scientific, Inc. (US)', 'Agilent Technologies, Inc. (US)', 'Sony Group Corporation (Japan)', 'Bio-Rad Laboratories, Inc. (US)', 'Miltenyi Biotec GmbH (Germany)', 'Enzo Biochem, Inc. (US)', 'Sysmex Corporation (Japan)', 'bioMérieux S.A. (France)', 'Cytonome/ ST, LLC (US)', 'Sartorius AG (Germany)', 'Cytek Biosciences, Inc. (US)', 'Union Biometrica, Inc. (US)', 'Fluxion Biosciences, Inc. (US)', 'Apogee Flow Systems Ltd. (UK)', 'Merck KGaA (Germany)', 'Beckman Coulter, Inc. (US)', 'Stratedigm, Inc. (US)', 'Nanocellect Biomedical (US)'

The increasing emphasis on the personalized medicine and targeted therapies is driving the demand for more advanced flow-through methods. The ability of flow cytometry to analyze multiple parameters simultaneously contributes to the accurate characterization of cells, which is crucial for developing personalized treatment plans.

Cell sorting is a pivotal segment of the flow cytometry market, appreciably enhancing the capability to split and analyze individual mobile populations based on specific characteristics. This procedure is essential for the various packages, consisting of cancer research, immunology, and stem mobile research. Advances in cell sorting technology permit researchers and clinicians to isolate rare cell types with high purity and accuracy, facilitating certain studies and personalized medicine procedures. The growing call for specific cellular analysis in both studies and clinical settings is driving the enlargement of this market section.

North America dominated the flow cytometry market. Throughout the forecast period, the region is predicted to dominate the marketplace. This dominance may be attributed to the United States' excessive healthcare spending and the healthcare infrastructure. Furthermore, the established pharmaceutical industry, as well as extensive research activities by research universities and pharmaceutical companies, have created a significant demand for the flow cytometry solutions for research purposes. North America dominated the overall market with 41.20% revenue share in 2023. This can be attributed in large part to the well-established healthcare and pharmaceutical industry in the US, which has driven the demand for flow cytometry solutions great for clinical and research purposes.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Flow Cytometry Market Competitive Landscape

Flow Cytometry Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Flow Cytometry Market Competitive Landscape

Flow Cytometry Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Flow Cytometry Market?

Who are the key vendors in the Flow Cytometry Market?

What is the key driver of Flow Cytometry Market?

What is the key market trend for Flow Cytometry Market?

Which region accounted for the largest share in Flow Cytometry Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300